|
Management
Sidney M. Baker, M.D., Chief Medical Director and Chairman
Dr. Baker is a practicing physician specializing in the biochemical and environmental aspects of the chronic health problems of children and adults. In May 1999, more than 500 of his fellow physicians from 24 different countries honored Dr. Baker with the Functional Medicine Linus Pauling Award at the Sixth International Symposium on Functional Medicine. The Linus Pauling Award recognized Dr. Baker's pioneering work over the last 20 years in developing the underlying principles of functional medicine, an emerging approach to medical practice that focuses on the biochemical and immunological balance of individuals.
Dr. Baker received both his B.A. degree (1960) and his M.D. degree (1964) from Yale University. He has specialty training in Obstetrics and is Board certified in Pediatrics and Environmental Medicine.
Dr. Baker began his professional life as an Assistant Professor of Medical Computer Sciences at Yale Medical School where he remained until 1971. In tandem with his clinical practice, he was also Assistant Clinical Professor for Pediatrics at Yale until 1981. Since 1971, Dr. Baker has practiced as a consultant for individuals with complex chronic illness.
Since his days at Yale, Dr. Baker has had an interest in the development of computer applications that help maintain accurate, detailed and structured medical records that allow physicians to make clinical portraits of patients both as individuals and as groups. Since the early 1970's, Dr. Baker has been working on pioneering on?line interactive medical history systems and batch input mechanisms for the handling of medical information. In developing software in the 1980's for use in physicians' offices, Dr. Baker created a database for his own practice that led to the accumulation of thousands of medical records. During that period, he worked on creating an internally consistent taxonomy of the everyday language in which patients communicate illness. This sustained development project proved the validity of the taxonomy underlying Medigenesis.
Dr. Baker is an author of several books and many articles on nutritional, biochemical and environmental aspects of chronic illness in adults and children.
Judith Gorman, M.S. Special Education, President and Chief Executive Officer
Judith Gorman's career has spanned several fields in both business and special education.
Ms. Gorman graduated from Columbia College with a BA in English literature and later managed the sales department of an international Wall Street bank. She returned to graduate school full-time in order to pursue a long-standing interest in education. In 1992, she graduated from Hunter College with a Master's Degree in Special Education and subsequently worked with physically and emotionally handicapped children within the New York City public school system and at the Jewish Guild for the Blind.
In 1995, Ms. Gorman began her professional involvement with the Internet after moving with her family to England. She assisted in setting up Wicked Web, a Web site design firm, acting in the dual role of Business Manager and HTML coder for what was then a 2-person firm. Wicked Web has since merged in an all-stock transaction with NetBenefit, an English domain name registrar, which went public in 1999 and is today one of the largest providers of comprehensive Web services in Europe. In 1999, Ms. Gorman continued her involvement with Internet start-ups and helped organize the imminent launch of education portal Fathom.com, a for-profit subsidiary of Columbia University.
Since her son became ill four years ago, Ms. Gorman has had intensely personal motivations to deepen her knowledge of the biological causes of autism and to improve the education of children with special needs. She has organized parents to fund autism research at the university level and has helped broaden the network of medical and educational information so that other families might more easily find the help that they need in raising an autistic child. In sum, Medigenesis is at the nexus of Ms. Gorman's interests in both the improvement of medical science's ability to understand and effectively treat illness and in the borderless, networked world of the Internet.
Nancy H. O'Hara, M.D., M.P.H., Deputy Medical Director
A practicing pediatrician, Dr. O'Hara specializes in treating children with chronic health and developmental problems. In addition to her work at Medigenesis, Dr. O'Hara has a pediatric practice in Fairfield County, Connecticut.
Dr. O'Hara is an Honors graduate of Bryn Mawr College where she was awarded a B.A. in Psychology, Magna Cum Laude, in 1984. Dr. O'Hara received her M.D. degree in 1988 from the University of Pennsylvania and was elected to the Medical Honor Society, Alpha Omega Alpha. In 1993, Dr. O'Hara was awarded the degree of Masters of Public Health by the University of Pittsburgh. Dr. O'Hara is Board certified in Pediatrics.
Since completing her formal education, Dr. O'Hara has practiced medicine with New England Pediatrics, LLP, with offices in New Canaan and Stamford, Connecticut, and is presently a principal of Consultative Integrative Practice for Children with Special Needs in New Canaan.
Dr. O'Hara is the co-author of several articles concerning pediatric medicine and is also a member of the American Academy of Pediatrics.
Back to top
Board of Directors
Sidney M. Baker, M.D., Founder, Chairman and Medical Director
Please see “ Management.”
Robert Brown, Ph.D., Operations Research
Dr. Robert Brown, Chairman and Chief Executive Officer of Health Products Research, Inc. (“HPR”), has been with that company since co-founding it in 1973. During his tenure, HPR was acquired by Snyder Communications in 1998 and, subsequently, spun off in September 1999 as a division of Ventiv Health, a $400 million company trading on the NASDAQ. As a leading international consulting company specializing in the health field, HPR has experienced a growth rate in excess of 20% a year over the last four years.
Dr. Brown holds a doctorate in Operations Research from George Washington University.
Prior to founding HPR, Dr. Brown was at Johnson & Johnson, where he served as Manager of Corporate Marketing Services. For 28 years, he has consulted on hundreds of projects for major pharmaceutical and medical products companies worldwide. His areas of specialization are strategic and tactical resource allocation and measurement of response to sales and marketing promotions to doctors and hospitals. His expertise also includes determination of optimal promotion and promotion mix levels as well as optimal sales force size, structure and alignment.
James A. Cutie
Mr. Cutie is a senior media and marketing executive with more than 25 years experience in areas spanning from general management and strategic planning to publishing, marketing, advertising sales, electronic media, licensing start-ups and capital formation. Since 1997, Mr. Cutie has been leading The Compass Group of Connecticut, LLC, the consulting firm that he founded. Mr. Cutie also serves as a member of the Advisory Board for Plum Holdings, LP, a Philadelphia-based investment firm specializing in early stage media companies.
A seventeen-year veteran of The New York Times Company, Mr. Cutie served most recently as President and Chief Executive Officer of The New York Times Information Services Group, one of the The Times' six operating divisions. In these roles, he successfully originated new electronic distribution channels through deals with Dow Jones, AOL, and Reed Elsevier among others.
During his tenure at The Times, Mr. Cutie led The New York Times News Service and Syndicate, and he directed several new business launches including @Times, one of the most successful publishing sites created on AOL; NYT Custom Publishing, a magazine unit that created premium publications for clients such as Four Seasons Hotels, IBM and US Airways; NYT New Media; and an array of multi-media products in partnership with companies including Time Warner, Viacom, and CBS. Prior to these activities, Mr. Cutie had been Senior Vice President of Marketing at The New York Times and National Advertising Director.
A native New Yorker, Mr. Cutie was a 1995-1996 David Rockefeller Fellow at the New York City Partnership Program. He earned his BA degree in Literature from Brooklyn College. Mr. Cutie resides with his family in Connecticut.
J. Paul Gorman
Mr. Gorman is Director of Business Development and a member of the Board of Directors of CyberElves, an international Web design and development company. Previously, Mr. Gorman was a Senior Vice President in the Emerging Markets trading department at Lehman Brothers. During his eight-year tenure at Lehman, Mr. Gorman was also in sales in the European government bond department in both the U.S. and in the U.K.
Prior to this, Mr. Gorman worked in trading at the Union Bank of Switzerland and at CNA Reinsurance, in the UK.
A native of England, Mr. Gorman has lived in the U.S. since 1990.
Judith Gorman, President and Chief Executive Officer
Please see “Management”
Charles G. Hertz, M.D., F.A.A.P.
Dr. Hertz recently retired as Vice President and Chief Medical Director of Metropolitan Life Insurance Company where his responsibilities included, among other things, Medical Life Underwriting, MetLife Insurance Testing Laboratory, Corporate Employee Health Services and the Corporate Wellness and Fitness Program. At MetLife, he edited Statistical Bulletin, a quarterly journal of demographic and healthcare trends. Prior to MetLife's sale of its managed care programs, Dr. Hertz was Mid-America Regional Director of Managed Care and President and Chief Executive Officer of MetLife Healthcare Network of Illinois, Inc. and MetLife HealthCare Network of Wisconsin, Inc.
Dr. Hertz received his Bachelor of Arts degree from Bucknell University in 1955 and was awarded a Doctor of Medicine degree by the University of Pennsylvania in 1959. He received diplomas from the American Board of Pediatrics and from the American Board of Quality Assurance and Utilization Review of Physicians.
After completing his formal education, Dr. Hertz initially practiced medicine in Philadelphia, first in private practice and later as part of Philadelphia Health Associates and predecessor groups. During his distinguished career, Dr. Hertz has held the following academic appointments: Associate Clinical Professor of Pediatrics, University of Pennsylvania (1974-86), Clinical Preceptor and Lecturer, Graduate Program, School of Nursing, University of Pennsylvania (1986) and Associate Clinical Professor of Pediatrics, Rush Medical College (1986-88).
At present, Dr. Hertz is consulting with international healthcare organizations, in particular concerning healthcare services in Eastern Europe.
James Sullivan, Esq.
Mr. Sullivan is a partner with the firm of Bleakley Platt & Schmidt, LLP (White Plains, New York) and is an active member of the firm's Commercial Lending Department and its Real Estate Department. Mr. Sullivan specializes in the documentation of a broad range of commercial credit facilities for lenders including mortgage loans, construction loans, revolving loans, lines of credit and term loans and has also developed extensive loan workout and mortgage foreclosure expertise. He served as a federal law clerk and in-house counsel to a major finance company and a money center bank prior to joining the firm in 1988.
Mr. Sullivan is a graduate of Long Island University (B.A., 1969) and New York Law School (J.D., 1972) where he was a contributing member of the Law Review. Mr. Sullivan is admitted to practice in New York, the Second Circuit Court of Appeals and the United States District Courts for the Southern and Eastern Districts of New York.
Since 1985, Mr. Sullivan has served as Town Attorney for the town of Pound Ridge, New York.
Since 1989, Mr. Sullivan has served as an outside Director of several special purpose corporations owned by Lehman Brothers Holdings, Inc. and/or its subsidiary and affiliate companies.
Back to top
Our Advisory Board
Sudhir Gupta, M.D., PhD.
Dr. Gupta is one of the preeminent immunologists in the world today. He holds professorships in Microbiology, Molecular Genetics, Neurology and Pathology at the University of California, Irvine. Dr. Gupta is also Vice Chairman of the Department of Medicine, Director of the Clinical Laboratory Immunology Training Program, Director of the Allergy and Immunology Training Program, and Chief of the Division of Basic and Clinical Immunology.
In addition to having authored and co-authored hundreds of articles in peer-reviewed literature, Dr. Gupta is Editor-in-Chief of the Journal of Clinical Immunology. He is a member of the Editorial Academy for the International Journal of Oncology and the Distinguished Advisory Board of the Journal of Basic and Applied Biomedicine. He also serves on the Editorial Board of Archivum Immunologiae et Therapiae Experimentalis as well as on the Scientific Advisory Board of Advances in Clinical and Experimental Medicine. Dr. Gupta also acts as a frequent ad hoc peer reviewer for 36 major medical publications including The New England Journal of Medicine.
Dr. Gupta received his Bachelors degree in Biology from Agra University in Agra, India and completed both his M.D. and PhD. at King George's Medical College, Lucknow University in Lucknow, India.
Kilmer S. McCully, M.D.
Dr. McCully is Chief of Pathology and Laboratory Medicine Service at the Veterans Affairs Medical Center in Providence, Rhode Island and Clinical Associate Professor of Pathology at Brown University.
A noted researcher in his field, Dr. McCully has studied extensively the relationship between homocysteine and atherosclerosis. The author and co-author of many peer-reviewed research publications in journals such as the American Journal of Pathology and Atherosclerosis, Dr. McCully is a frequent presenter at academic medical symposia around the world. In 1998, the Institute for Functional Medicine awarded Dr. McCully with its Linus Pauling Functional Medicine Award for his contributions to medical research. Since receiving this prestigious award, eight other scientific and medical institutions have recognized the importance of Dr. McCully's research which has provided a unifying theory of the pathology underlying cardiovascular disease and cancer.
Dr. McCully is a graduate of Harvard College with an A.B. in Chemistry. He earned his medical degree at Harvard Medical School. He has been the recipient of fellowships from the National Institute of Mental Health, Massachusetts General Hospital, Glasgow University, and Harvard University. In addition to his clinical and research work, Dr. McCully has been a professor of pathology since the mid 1960s at institutions including Harvard, MIT, and the University of Connecticut.
Jon Pangborn, PhD.
Trained as a chemical engineer, Dr. Pangborn has been a researcher and consultant in the fields of nutritional biochemistry, metabolism and detoxification for more than 20 years. He is founder and president of Bionostics, Inc., a consulting firm to physicians, clinics, and clinical laboratories on matters relating to nutritional remedies and testing for problems relating to metabolism and toxicity. Dr. Pangborn is also Adjunct Professor of Nutritional Biochemistry at The Union Institute and a Fellow of the American Institute of Chemists.
Dr. Pangborn's research has focused on the functions of amino acids, organic acids and essential nutrients. His work has led to the development of nutritional products such as pyridoxal 5-phosphate (coenzyme form of vitamin B6) and alpha-ketoglutarate (an important organic acid), both of which are widely available today. A member of the Autism Research Institute's advisory board, Dr. Pangborn coauthored the Consensus Report for clinical testing of autistics--The DAN! Protocol--with Medigenesis founder Dr. Sidney M. Baker. Additionally, Dr. Pangborn is the author of 9 issued US patents and over 250 scientific presentations and publications.
Dr. Pangborn received his Ph.D. in Chemical Engineering from the University of Syracuse. He is a recipient of the American Academy of Environmental Medicine's Herbert J. Rinkel Award and a member of the Scientific Council for the International and American Associations of Clinical Nutritionists.
Candace Pert, PhD.
Dr. Pert is Research Professor in the Department of Physiology and Biophysics at the Georgetown University School of Medicine in Washington D.C. She was previously a researcher at the National Institute of Health's National Institute of Mental Health from 1975 to 1987. For five of those years Dr. Pert was Chief of Brain Biochemistry Research for the institute's Clinical Neuroscience Branch.
A graduate of Bryn Mawr College, Dr. Pert was awarded a doctorate in pharmacology from The Johns Hopkins University School of Medicine in 1974. She has published over 200 articles in peer-reviewed journals including the Journal of Immunology, the Journal of Neuroscience, Clinical Immunology, The Lancet, Science, and Nature.
Joseph E. Pizzorno, Jr., N.D.
A founder of Bastyr University (the first fully accredited, multidisciplinary university dedicated to the study of natural medicine in the United States), Dr. Pizzorno is a licensed naturopathic physician and a leading expert in science-based natural medicine. Following his twenty-two-year tenure as president of Bastyr University, Dr. Pizzorno is president emeritus and senior advisor to the university's president. The author and co-author of internationally acclaimed books such as Total Wellness, the Textbook of Natural Medicine and the Encyclopedia of Natural Medicine, Dr. Pizzorno recently founded Salugenecists, Inc., a company dedicated to creating science-based, natural medicine health-advice systems.
President Clinton appointed Dr. Pizzorno to the White House Commission on Complementary and Alternative Medicine Policy. In September 2000, Dr. Pizzorno received the Humanitarian of the Year award from the Cancer Treatment Centers of America.
Bernard Rimland, PhD.
Dr. Rimland, a research psychologist, is Director of the Autism Research Institute in San Diego California. He founded the organization in 1967 after having established the Autism Society of America in 1965. Along with his work at the Autism Research Institute, Dr. Rimland edits the Autism Research Review International.
A world-renowned lecturer on autism and its related problems, Dr. Rimland is the author of numerous publications. Notably, his prize-winning book, Infantile Autism: The Syndrome and Its Implications for a Neural Theory of Behavior (1964) was instrumental in redirecting the focus of autism research away from the theory that the illness was an emotional one caused by destructive mothers to the current understanding that autism is a biological disorder.
Lloyd Saberski, M.D.
Dr. Saberski is Medical Director of Advanced Diagnostic Pain Treatment Centers, a private practice privileged at Yale New Haven Hospital and dedicated to the management of chronic painful disorders. He also acts as a consultant to health organizations including Medicare, Blue Cross and Blue Shield and Oxford Health. A widely published author, Dr. Saberski has written for journals such as Anesthesia and Analgesia, The Yale Journal of Biology and Medicine and the Journal of Anesthesia.
Following a fellowship in Pain Management and Obstetrical Anesthesiology, Dr. Saberski joined the faculty at Yale University Medical School in the Pain Management Section of the Department of Anesthesia. He founded the Yale University Fellowship in Pain Management and served as its director from its inception until 1998. His most recent position at the university was that of Medical Director of the Center for Pain Management.
A graduate of New York Medical College, Dr. Saberski completed residencies in Internal Medicine and Anesthesiology at the Albany Medical College. He is board certified in Internal Medicine, Anesthesiology and Pain Management.
Paul Shattock, PhD., O.B.E
Dr. Shattock is Director of the Autism Research Unit at the University of Sunderland's School of Health Sciences in the United Kingdom. He is also Senior Lecturer Emeritus in Pharmacology at the university. The Autism Research Unit was founded in 1982 for the purposes of researching possible causes of autism and collecting the body of past and current research on the illness.
In addition to his research at the School of Health Sciences, Dr. Shattock is a member of the Council of Administrators of Autism-Europe, the pan-European association dedicated to advancing the rights of people with autism and their families as well as to helping to improve their lives.
Dr. Shattock is an Officer of the Order of the British Empire, one of the highest civilian honors awarded in the United Kingdom.
Andrew Wakefield, M.D.
Dr. Wakefield is a medical doctor specializing in Gastroenterology. He holds the distinguished title of Reader in the University Departments of Medicine and Histopathology at the Royal Free Hospital School of Medicine in London, England. Dr. Wakefield also acts as Director of Research and Chairman of the Inflammatory Bowel Disease Study Group at the unversity. Dr. Wakefield has authored and co-authored many articles in distinguished, peer-reviewed publications such as The Lancet.
A native of the UK, Dr. Wakefield completed his medical studies at St. Mary's Hospital Medical School in London.
Back to top
| 
